Marché Fermé -
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
1 621 GBX | -0,49 % | +1,44 % | +11,78 % |
Métier
Nombre d'employés: 70 212
Ventes par activité
GBP en Millions | 2022 | Poids | 2023 | Poids | Delta |
---|---|---|---|---|---|
Commercial Operations
100,0
%
| 29 324 | 100,0 % | 30 328 | 100,0 % | +3,42 % |
Ventes par région
GBP en Millions | 2022 | Poids | 2023 | Poids | Delta |
---|---|---|---|---|---|
United States
52,2
%
| 14 542 | 49,6 % | 15 820 | 52,2 % | +8,79 % |
Rest of World
45,6
%
| 14 087 | 48,0 % | 13 815 | 45,6 % | -1,93 % |
United Kingdom
2,3
%
| 695 | 2,4 % | 693 | 2,3 % | -0,29 % |
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Emma Walmsley
CEO | Chief Executive Officer | 55 | 01/05/10 |
Julie Brown
DFI | Director of Finance/CFO | 62 | 01/05/23 |
James Ford
CMP | Compliance Officer | - | 01/08/95 |
Amy Altshul
CTO | Chief Tech/Sci/R&D Officer | - | - |
Chief Tech/Sci/R&D Officer | - | 01/01/18 | |
Tony Wood
CTO | Chief Tech/Sci/R&D Officer | - | 01/08/17 |
Hal Barron
BRD | Director/Board Member | 62 | 01/01/18 |
David Redfern
PRN | Corporate Officer/Principal | 57 | 01/01/94 |
Frannie DeFranco
PRN | Corporate Officer/Principal | - | 01/09/10 |
Claire Lund
PRN | Corporate Officer/Principal | - | - |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Julie Brown
DFI | Director of Finance/CFO | 62 | 01/05/23 |
Jonathan Symonds
CHM | Chairman | 66 | 01/09/19 |
Hal Barron
BRD | Director/Board Member | 62 | 01/01/18 |
Vishal Sikka
BRD | Director/Board Member | 57 | 18/07/22 |
Wendy Becker
BRD | Director/Board Member | 58 | 01/10/23 |
Charles Bancroft
BRD | Director/Board Member | 65 | 01/05/20 |
Anne Beal
BRD | Director/Board Member | 62 | 06/05/21 |
Emma Walmsley
CEO | Chief Executive Officer | 55 | 01/05/10 |
Director/Board Member | 66 | 01/09/22 | |
Jesse Goodman
BRD | Director/Board Member | 72 | 01/01/16 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 4 314 134 937 | 4 078 485 190 ( 94,54 %) | 169 171 155 ( 3,921 %) | 94,54 % |
Participations
Nom | Actions | % | Valorisation |
---|---|---|---|
127 054 524 | 75,00% | 4 004 128 406 $ | |
HALEON PLC 4,22% | 385 320 110 | 4,22% | 1 594 905 440 $ |
263 029 794 | 82,59% | 119 134 085 $ | |
HALEON PAKISTAN LIMITED 85,79% | 100 423 259 | 85,79% | 91 315 874 $ |
VIR BIOTECHNOLOGY, INC. 6,28% | 8 550 954 | 6,28% | 87 818 298 $ |
WAVE LIFE SCIENCES LTD. 11,42% | 13 983 761 | 11,42% | 86 419 643 $ |
LYELL IMMUNOPHARMA, INC. 11,87% | 30 253 189 | 11,87% | 83 801 334 $ |
CUREVAC N.V. 7,40% | 16 591 937 | 7,40% | 64 542 635 $ |
GLAXOSMITHKLINE S.A.E 91,20% | 76 161 378 | 91,20% | 45 239 859 $ |
BICYCLE THERAPEUTICS PLC 4,03% | 1 529 561 | 4,03% | 33 940 959 $ |
Coordonnées société
Sociétés du groupe
Nom | Catégorie et Secteur |
---|---|
GlaxoSmithKline Asia Pvt Ltd.
GlaxoSmithKline Asia Pvt Ltd. Pharmaceuticals: MajorHealth Technology Part of GSK Plc, GlaxoSmithKline Asia Pvt Ltd. is an Indian company that produces bacterial and virus vaccines and other pharmaceutical products. The company is based in Gurgaon, India. |
Pharmaceuticals: Major
|
GSK Capital KK
|
Finance/Rental/Leasing
|
Horlicks Ltd.
Horlicks Ltd. Beverages: AlcoholicConsumer Non-Durables Horlicks Ltd. manufactures and distributes infant food products. The products it offers are Horlicks traditional, light and light chocolate. The company was founded on December 11, 1925 and is headquartered in Brentford, the United Kingdom. |
Beverages: Alcoholic
|
GlaxoSmithKline GmbH & Co. KG
GlaxoSmithKline GmbH & Co. KG Pharmaceuticals: MajorHealth Technology Part of GSK Plc, GlaxoSmithKline GmbH & Co. KG is a German pharmaceutical company. The company is based in Munich, Germany. The CEOs of the company are Jean-Bernard Siméon, Adrian Bauer. |
Pharmaceuticals: Major
|
Setfirst Ltd.
Setfirst Ltd. Financial ConglomeratesFinance Part of GSK Plc, Setfirst Ltd. functions as an investment holding British company. The company is based in Middlesex, UK. |
Financial Conglomerates
|
GlaxoSmithKline Pte Ltd.
GlaxoSmithKline Pte Ltd. Pharmaceuticals: OtherHealth Technology GlaxoSmithKline Pte Ltd. engages in pharmaceutical products. It provides prescription medicines, vaccines, and consumer healthcare services. The company is headquartered in Gateway West, Singapore. |
Pharmaceuticals: Other
|
SmithKline Beecham Overseas Ltd.
SmithKline Beecham Overseas Ltd. MiscellaneousMiscellaneous Founded in 1990, SmithKline Beecham Overseas Ltd. is a British holdings company that operates as a subsidiary of GSK Plc. The company is based in Middlesex, UK. |
Miscellaneous
|
GlaxoSmithKline Capital Plc
|
Finance/Rental/Leasing
|
GlaxoSmithKline Export Ltd.
GlaxoSmithKline Export Ltd. Medical DistributorsDistribution Services Part of GSK Plc, GlaxoSmithKline Export Ltd. is a British biopharma company founded in 1989. The company is based in Middlesex, UK. GlaxoSmithKline Export aims to unite science, technology, and talent to get ahead of disease together. The company's pipeline is focused on unlocking the science of the immune system and advanced technologies to develop innovative vaccines and medicines. |
Medical Distributors
|
Secteur
Ventes par activité
Ventes par région
Révisions de BNA
Varia. 1 janv. | Capi. | |
---|---|---|
+11,78 % | 84,52 Md | |
+45,82 % | 765 Md | |
-6,16 % | 354 Md | |
+19,86 % | 331 Md | |
+9,32 % | 299 Md | |
+18,85 % | 248 Md | |
-1,51 % | 219 Md | |
+11,11 % | 216 Md | |
+5,90 % | 164 Md | |
-0,73 % | 162 Md |
- Bourse
- Actions
- Action GSK
- Société GSK plc